NCT03642756

Brief Summary

The aim of this study is to compare the effects of different intra-arterial catheter size on the frequency of optimal dynamic response in radial arterial waveform.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
366

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Oct 2018

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

July 27, 2018

Completed
26 days until next milestone

First Posted

Study publicly available on registry

August 22, 2018

Completed
1 month until next milestone

Study Start

First participant enrolled

October 1, 2018

Completed
1 year until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 1, 2019

Completed
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2019

Completed
Last Updated

August 22, 2018

Status Verified

August 1, 2018

Enrollment Period

1 year

First QC Date

July 27, 2018

Last Update Submit

August 21, 2018

Conditions

Outcome Measures

Primary Outcomes (1)

  • The frequency of adequately damped arterial waveform

    The accuracy of arterial blood pressure waveform is depedent on damping coefficient (DC) and natural frequency (NF). The extent to which a monitoring system is damped is expressed by the DC, while the frequency of oscillation that a monitoring system resonates at is known as the NF. The NF and DC are required to be within certain rages for accurate blood pressure monitoring, and they can be affected by different arterial catheter size. Adequately damped arterial waveform can be defined as NF and DC being within certain ranges. For example, waveforms with DC of 0.5 at a NF of 15Hz can be regarded as adequately damped arterial waveform. However, if waveforms have DC of 0.1 at a NF of 15Hz, these can be regarded as not having optimal dynamic response. (There is a reference figure explaining these factors in detail in a previous article. Gardner RM: Direct blood pressure measurement--dynamic response requirements. Anesthesiology 1981; 54:227-3)

    1 minute after cannulation

Secondary Outcomes (1)

  • The difference of mean blood pressure between invasive blood pressure and non-invasive blood pressure

    1 minute after cannulation

Study Arms (3)

20 gauge

PLACEBO COMPARATOR
Device: different intra-arterial catheter size

22 gauge

ACTIVE COMPARATOR
Device: different intra-arterial catheter size

24 gauge

ACTIVE COMPARATOR
Device: different intra-arterial catheter size

Interventions

in placebo group, patients were cannulated with 20 gauge intra-arterial catheter. In experiment groups, patients were cannulated with 22 gauge or 24 gauge intra-arterial catheter.

20 gauge22 gauge24 gauge

Eligibility Criteria

Age20 Years - 79 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • patients who were scheduled for elective neurosurgery under general anesthesia
  • patients with age of 20-79 and ASA class I-III
  • patients who are needed to establish invasive arterial pressure monitoring

You may not qualify if:

  • patients who refuted to be involved in the study
  • patients with age of \<20 or \>80
  • patients who had both arm saved
  • patients who had a previous history of surgery on radial artery

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Seoul National University Hospital

Seoul, South Korea

Location

Related Publications (1)

  • Oh H, Choe SH, Kim YJ, Yoon HK, Lee HC, Park HP. Intraarterial catheter diameter and dynamic response of arterial pressure monitoring system: a randomized controlled trial. J Clin Monit Comput. 2022 Apr;36(2):387-395. doi: 10.1007/s10877-021-00663-7. Epub 2021 Feb 1.

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, OUTCOMES ASSESSOR
Purpose
DIAGNOSTIC
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor

Study Record Dates

First Submitted

July 27, 2018

First Posted

August 22, 2018

Study Start

October 1, 2018

Primary Completion

October 1, 2019

Study Completion

December 1, 2019

Last Updated

August 22, 2018

Record last verified: 2018-08

Data Sharing

IPD Sharing
Will not share

Locations